125114-76-3

Basic information

• Product Name: 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile
• Synonyms: 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile
• CAS NO: 125114-76-3
• Molecular Weight: 159.18456
• EINECS: -0
• Mol File: 125114-76-3.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile(125114-76-3)
• EPA Substance Registry System: 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile(125114-76-3)

Safety Data

• Hazardous Substances Data: 125114-76-3(Hazardous Substances Data)

Usage

Explanation

The compound consists of 10 carbon atoms, 7 hydrogen atoms, 1 nitrogen atom, and 1 oxygen atom.

Explanation

The structure of 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile consists of two interconnected aromatic rings.

Explanation

This compound is derived from 1-hydroxy-2,3-dihydro-1H-indene by the addition of a nitrile group (C≡N).

Explanation

Due to its unique chemical structure and properties, 1-hydroxy-2,3-dihydro-1H-indene-4-carbonitrile may have uses in the development of pharmaceuticals.

Explanation

As a nitrile compound, it can be toxic if ingested or inhaled, necessitating careful handling and further research to understand its potential risks.

Upstream product

• 15115-60-3 4-bromo-2,3-dihydroinden-1-one 
• 25724-79-2 5-cyano-1-indanone 
• 60899-34-5 4-cyano-2,3-dihydro-1H-inden-1-one 

Downstream Products

• 1307230-43-8 4-(5-(3,4-diethoxybenzyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol 
• 1201446-74-3 N₁-(4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-N₂,N₂-diethylethane-1,2-diamine 
• 1094042-01-9 CYM-5442 
• 1201446-43-6 4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-one 
• 1093827-52-1 (±)-4-(5-(3,4-diethoxyphenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol 
• 1201447-94-0 4-(5-(4-ethoxy-3-nitrophenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol 
• 1201447-11-1 2-(4-(5-(4-ethoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanol 
• 1201447-09-7 2-(4-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ylamino)ethanol 
• 1201447-07-5 2-ethoxy-5-(3-(1-hydroxy-2,3-dihydro-1H-inden-4-yl)-1,2,4-oxadiazol-5-yl)benzonitrile 
• 1201447-03-1 4-(5-(4-ethoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol 
• 1201447-01-9 4-(5-(4-isopropoxy-3-(trifluoromethyl)phenyl)-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-ol 

Relevant articles and documents

FUSED PYRAZOLE AND IMIDAZOLE BASED COMPOUNDS AND USE THEREOF AS GLI1 INHIBITORS

The present invention is directed to a composition and a method for use thereof, such as for the treatment and prevention of a neurological disorder or cancer in a subject.

HETERCYCLIC COMPOUNDS FOR THE TREATMENT OF DISEASE

Described herein are heterocyclic compounds, compositions, and methods for their use for treatment of disease.

NOVEL 3-HYDROXY-5-ARYLISOXAZOLE DERIVATIVE

[Problem] To provide a GPR40 activating agent having, as an active ingredient, a novel compound having a GPR40 agonist action, a salt of the compound, a solvate of the salt or the compound, or the like, particularly, an insulin secretagogue and a prophylactic and/or therapeutic agent against diabetes, obesity, or other diseases. [Means of solving the problem] A compound of Formula (I): (where p is 0 to 4; j is 0 to 3; k is 0 to 2; a ring A is a specific cyclic group; a ring B is a benzene ring, a pyridine ring, or a pyrimidine ring; X is —CH2—, O, —S(O)i— (i is 0 to 2), or —NR7—; R1 to R6 are specific groups), a salt of the compound, or a solvate of the salt or the compound.